BDSX

Biodesix Stock Analysis

AI Rating

Fair
  • Quality0/10
  • Growth 6/10
  • Value 1/10
Biodesix sales and earnings growth
BDSX Growth
Good
  • Revenue Y/Y 29.05%
  • EPS Y/Y 27.93%
  • FCF Y/Y 44.20%
Biodesix gross and profit margin trends
BDSX Profitability
Neutral
  • Gross margin 82.10%
  • EPS margin -33.30%
  • ROIC 5Y -54.82%
Biodesix net debt vs free cash flow
BDSX Risk
Poor
  • Debt / Equity 7.8
  • Debt / FCF 1.8
  • Interest coverage -3.0

Biodesix stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.

↗ More Diagnostics & Research stocks